Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of ADACEL as Fifth Dose in Children 6-8 Years
NCT00258908Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2005
- Primary completion
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of acellular pertussis vaccine in diphtheria, Tetanus, pertussis, sponsored by Sanofi. Started Nov 2005; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT00258908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258908.